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Abstract 
Background and objectives: Human adenoviruses cause a wide range of diseases, from self-limiting 
and mild infections to some life-threatening infections. Many studies have shown that components 
derived from medicinal plants have antiviral activity. Pistacia genus is rich in phenolic compounds and 
has antioxidant and antimicrobial effects. The aim of this study was to investigate antioxidant potential 
and antiviral effects of ethanol and crude extracts and different fractions of Pistacia atlantica Desf. 
leaves on adenovirus. Methods: Crude P. atlantica leaf extract was prepared by maceration with 80% 
ethanol. Hexane, chloroform, ethyl acetate and n-butanol fractions were prepared using liquid-liquid 
extraction method. Toxicity on HEp-2 cells and anti-adenoviral activity of the extract/fractions were 
evaluated by MTT colorimetric methods. The concentration that caused 50% viral inhibition (IC50) and 
50 % cytotoxicity concentration (CC50) were evaluated using regression analysis. Selectivity index (SI), 
as a marker of antiviral activity, was calculated. To determine antioxidant activity the 2, 2-diphenyl-1-
picrylhydrazyl (DPPH) assay was used. Results: Ethyl acetate fraction showed the highest antioxidant 
activity with IC50 of 1.54±0.12 μg/mL in DPPH scavenging assay. Based on our results, IC50 of P. 
atlantica crude extract on adenovirus was 15.72 μg/mL, with SI of 8.09; n-butanol fraction showed the 
highest anti-adenoviral activity among the fractions with IC50 of 16.38 µg/mL and SI of 26.5. 
Conclusion: The ethanol extract and n-butanol fraction of P. atlantica leaves showed inhibitory effects 
on adenovirus and could be a new promising anti-adenovirus agent.  
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Introduction 
Adenovirus (ADV) is a non-enveloped virus with 
a linear double-stranded DNA (dsDNA) that 
encodes 30-40 proteins. Similar to with other 
mammalian adenoviruses, human ADVs are 
classified into the genus Mastadenovirus (mastós, 
breast) [1]. Human ADV is associated with 
various human diseases such as myocarditis, 
conjunctivitis, gastroenteritis, hepatitis, and 
pneumonia. Generally, human ADVs are not 
highly pathogenic viruses because they are mostly 
associated with self-limiting respiratory infections, 
hemorrhagic cystitis and gastroenteritis, 
particularly in infants and young children [2]. In 
addition, ocular ADV infection is one of the 
leading reasons for viral conjunctivitis.  
During the last two decades, the incidence of 
severe and life-threatening ADV infections has 
risen due to the growing transplantation, strong 
immunosuppressive therapies and the emergence 
of the HIV epidemic. 
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Much evidence is available regarding the in vivo 
efficacy of antiviral therapy against human ADV 
in the preemptive setting for cidofovir [3], but the 
clinical effect of the drug for treatment of overt 
viral disease has not yet been widely demonstrated 
[4]. Although resistant mutants have been 
described in vitro, cidofovir is obviously effective 
on all human ADV species [5] and is currently the 
primary anti-HAdV agent for preemptive therapy 
[3,6]. 
The challenges facing cidofovir treatment include 
its low bioavailability and poor correlation of 
pharmacological effects with the prescribed dose 
[7]. Besides, cidofovir can show a dose-limiting 
nephrotoxicity, and repeated monitoring of renal 
and tubular function along with hydration using 
probenecid is also sensible [4]. 
In regards to the growth of numbers of 
immunosuppressed patients, it is necessary to 
develop alternative anti-ADV treatment drugs. 
Medicinal plants have long been used to treat 
human diseases and a number of herbal medicines 
have been developed into therapeutic agents with 
satisfactory results. Plants are able to synthesize a 
wide spectrum of compounds and have long been 
used as remedies. Numerous plants are also being 
studied to detect drug sources. 
Pistacia species appear as tree or shrub and 
creeping plants that include over 17 species across 
the world. Pistacia atlantica Desf. (wild pistachio), 
Pistacia vera and Pistacia khinjuk are three 
species that grow in Iran [8]. Different parts of 
Pistacia are widely used in traditional medicine of 
Iran and other countries. In Turkish native 
medicine, P. atlantica gum is used for respiratory 
and urinary tract infections and in Iran, it is used 
as a potent laxative in the treatment of constipation 
and gastrointestinal disorders. Aerial parts of the 
plant are traditionally used to treat eczema, tremor, 
throat infection, diarrhea, kidney stones, asthma, 
and gastric disease. The leaves of the plant have 
traditionally been used in Jordan for diabetes and 
eye infection. The fruit are used in Asian countries 
like Jordan and Turkey for gastric pain, oral 
diseases and to treat cough, diarrhea and stress [8]. 
In different studies, antimicrobial effects of 
Pistacia on several bacterial species, fungi and 
yeast have been evaluated and the results have 
shown that the leaf extract of different species of 
Pistacia shows inhibitory effects on the Gram-
positive and Gram-negative bacteria, Candida 
albicans, Aspergillus flavus, Rhizopus stolonifer, 
Trichoderma, and Fusarium [8,9]. 
So far, no study has evaluated the antiviral effects 
of P. atlantica, but the antiviral effects of other 
species of Pistacia have been studied. Özçelik et 
al. investigated the antibacterial, antifungal and 
antiviral effects of the extracts of different parts of 
P. vera and found that these extracts showed low 
antibacterial and antifungal effects. These extracts 
also showed high antiviral effects against herpes 
simplex and para-influenza viruses; the seed and 
kernel extract showed comparably more potent 
effects than other plant organs [10]. Besides, 
another study on the antiviral effects of 75 plant 
species against herpes virus, Sindbis virus and 
Poliovirus showed that P. lentiscus extract 
exhibited the highest antiviral activity against 
herpes virus [11]. 
The study by Rashed et al. also showed the 
antiviral effects of flavonoids isolated from 
Pistacia chinensis extract against hepatitis C virus 
[12]. Due to the lack of effective treatment for the 
above-mentioned viral infections and the 
numerous side effects of drugs currently used, 
there is an increasing demand for novel antiviral 
compounds.  
Regarding the antimicrobial and antiviral effects 
of other species of this plant, in the present study, 
the phytochemical properties and antiviral effects 
of ethanol extract and various components of P. 
atlantica leaf against adenovirus were 
investigated in vitro. 
 
Materials and Methods 
Ethical considerations 
The protocol of study was reviewed and 
confirmed by the Ethics Committee of Shahrekord 
University of Medical Sciences (registration code: 
IR.SKUMS.REC.1396.197). 
 
Plant collection, extraction and fractionation 
Pistacia atlantica leaves were collected in 
summer 2017 from the mountains around 
Lordegan, southwest of Iran. Then plant was 
identified and confirmed (herbarium number 
MPSKUMS-93) at the Herbarium of Medical 
Plants Research Center, Shahrekord University of 
Medical Sciences (Iran). The leaves were 
pulverized (100 g) and dissolved in 80% ethanol 
(400 mL) and left at room temperature for 96 h. 
Then, the mixture was filtered and concentrated 
under vacuum pressure at 40 °C in a rotary 
evaporator. Four fractions of the crude extract 
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with different polarities were prepared by in-
solution isolation using the difference in the 
polarities of various secondary metabolites (figure 
1). The crude extract was dissolved in ethyl 
alcohol/H2O and fractionated by consecutive 
liquid/liquid partitioning with n-hexane (Merck, 
Germany), and then with chloroform, ethyl acetate, 
and n-buthanol (Merck, Germany) by increasing 
polarity order [13].  
 
Determination of free-radical scavenging 
activity  
The free-radical scavenging activity of P. 
atlantica extract and fractions were measured by 
2, 2 diphenyl-1-picrylhydrazyl (DPPH) method 
described by Moon and Terao [14] with some 
modifications. Briefly, different amounts of the 
extract and methanol were added to 0.3 mg/mL 
methanolic solution of DPPH to a total volume of 
3.0 mL. After the solution was left for 15 min at 
room temperature, its absorbance was read at 517 
nm by UV-Vis spectrophotometer (UNICO 2100, 
USA). Butylated hydroxytoluene (BHT) was used 
as the positive control. Inhibition of free radical by 
DPPH was calculated as follows:   
 
Antiradical activity (%) = [(A control – A sample)/A 
control]×100 
 
The IC50 value was defined as the amount of 
antioxidant needed to reduce the initial DPPH 
concentration by 50%. The value was determined 
based on linear regression of plots of the 
percentage of antiradical activity against the 
concentration of the compounds [15]. The 
experiment was carried out in triplicate. 
 
Cell culture and virus propagation 
HEp-2 (cervix adenocarcinoma) cells was 
purchased from Pasteur Institute of Iran. The cells 
were grown in Dulbecco’s Modified Eagle’s 
Medium (DMEM; Gibco, USA) supplemented 
with 10% fetal bovine serum (FBS; Gibco, USA), 
100 μg/mL of streptomycin, 100 UI/mL of 
penicillin, and 0.25 μg/mL amphotericin B (Gibco, 
USA) at 37 °C and 5% CO2. The same medium 
containing 1.5% FBS was used for cytotoxicity 
and antiviral assays. ADV (type 5) was kindly 
provided by the Health Faculty of Tehran 
University of Medical Sciences, Tehran, Iran. 
Virus stock was prepared by infection of confluent 
monolayer HEp-2 cells in 75 cm2 culture flasks 
using DMEM medium with 1.5% FBS, at 37 °C in 
5% CO2. Virus titer was measured by the 
cytopathic effect (CPE) of ADV in HEp-2 cells 
and was expressed as the 50% tissue culture 
infective dose (TCID50) per mL. 
 
 
Figure 1. Flow chart for the extraction and fractionation of Pistacia atlantica leaves 
 
 
Ground Pistacia atlantica leaves 
(100 g) 
Extraction with 80% ethyl alcohol 
Using maceration method for 96h 
Filtration 
Evaporation 
Crude extract 
(13.08 g) 
Dissolving in ethyl alcohol/H2O 
and fractionation with n-hexane 
Hexane fraction 
(520 mg) 
Residue 
Dissolving in ethyl alcohol/H2O 
and fractionation with chloroform 
Residue Chloroform fraction 
(1.37 g) 
Concentration and 
fractionation with ethyl acetate 
Ethyl acetate fraction 
(1.95 g) 
Residue 
Fractionation with n-butanol 
Residue n-butanol fraction 
(1.58 g) 
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Cytotoxicity assay 
The effects of the extract and fractions on the 
viability of HEp-2 cells were determined using 3-
(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbrome (MTT; Sigma, USA) 
assay according to a previously described method 
[16,17] with certain modifications. Briefly, when 
the cell monolayer became confluent onto 96-well 
plates, the cells were incubated with 150 µL/well 
of various concentrations of the extract/fractions 
at 37 °C with 5% CO2 for 96 h (in triplicate). 
Afterwards, cell monolayers were incubated with 
50 μL of 1 mg/ml MTT in PBS at 37 °C for 4 h, 
and then treated with 100 μL of acidic isopropanol 
(0.05 N HCl in absolute isopropanol). After the 
plates were shaken for 15 min, the absorbance was 
read using a reference filter at 570 nm with a 
microplate reader (StataFax2100, USA). Data 
were expressed as the percentage of toxicity using 
the following formula:  
 
Toxicity (%) = [100– (At/As) × 100]% 
 
Where At and As represent the absorbance of the 
test substance and the solvent control, respectively. 
The 50% cytotoxicity concentration (CC50) was 
defined as the cytotoxic concentration of the crude 
extract/fractions according to regression analysis. 
 
Antiviral assay  
Antiviral activity of P. atlantica extract and 
fractions were evaluated using inhibitory activity 
assay by means of MTT method, as described 
previously [16]. In summary, when the cell 
monolayer became confluent in 96-well plates, the 
cell culture medium was aspirated, rinsed with 
PBS, and then infected with 100 TCID50 (100 μL) 
of virus suspension for 2 h to allow virus 
adsorption, and then the virus was removed and 
the cells were treated with serial two fold dilutions 
of nontoxic concentration of the extract/fractions 
in triplicate. To obtain positive control, cells were 
infected with the same concentration of virus but 
without the addition of extract. To obtain negative 
or cell control, only DMEM and 1.5% FBS were 
added to the cells. The plates were incubated at 
37 °C in a humidified CO2 atmosphere for 4 days 
[13]. Cell viability was also determined using 
previously described MTT assay [16]. At each 
stage, negative control (without viruses and plant 
compounds) and virus control (viruses without 
plant components) were also designed. The 
percentage of viral inhibition was calculated as the 
percentage of inhibition using the following 
formula [17,18]: 
 
Antiviral activity (%) = (Atv−Acv)/(Acd −Acv) × 
100 % 
 
Where Atv, Acv, and Acd are the absorbance of 
the test compounds on virus-infected cells, the 
absorbance of the virus control, and the 
absorbance of the cell control, respectively. 
Finally, after three replications, IC50 was 
calculated as the minimum concentration of plant 
compounds capable of inhibiting 50% of viruses 
using a regression plot. Selectivity index (SI), as a 
marker of antiviral activity, was determined as the 
ratio of CC50 to IC50.  
 
Statistical analysis 
The IC50 and CC50 values were calculated by 
regression analysis using GraphPad Prism 6 
(GraphPad Software, La Jolla, CA). All 
measurements were done in triplicate and 
statistical analysis was done by statistical software 
using one-way analysis of variance (ANOVA) and 
the post-hoc Tukey’stest. 
 
Results and Discussion 
Our results showed that the scavenging effect of 
the extract/fractions increased as the concentration 
increased. The extract/ fractions of P. atlantica 
significantly reduced the DPPH. The Ethyl acetate 
fraction showed the highest antioxidant activity 
with IC50 of 1.54±0.12 μg/mL for DPPH radicals, 
the chloroform fraction, n-butanol fraction, and 
the total extract had IC50 values of 3.4±0.11, 3.66± 
1.52, and 4.6±0.66μg/mL, respectively, and the n-
hexane fraction showed the highest value 
(14.84±2.07). The results were expressed relative 
to butylated hydroxytoluene (BHT), a reference 
standard having IC50 of 33.5±3.67 μg/mL. The 
IC50 values of the chloroform fraction, the n-
butanol fraction, and the total extract, were found 
to be significant (p<0.05) as compared with BHT. 
Cytotoxic activities of the extract and fractions 
were investigated using HEp-2 cell line. The CC50 
of P. atlantica crude extract on HEp-2 cells was 
127.2 μg/mL. The n-butanol fraction showed the 
lowest cytotoxic activity with the highest CC50 of 
434.7 μg/mL. Other fractions, including ethyl 
acetate, chloroform and n-hexane, showed CC50 of 
32.38, 64.5 and 302.2 μg/mL, respectively (table 1).  
Anti-adenovirus and antioxidant activity of Pistacia atlantica 
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The analysis demonstrated that the concentrations 
of extract and fractions were significantly 
associated with the cell death (p<0.05, figure 2). 
To evaluate the effect of P. atlantica extract and 
fractions on adenovirus-infected HEp-2 cells, the 
cells were treated with non-cytotoxic 
concentrations of extract/fractions for 4 days to 
investigate the cytopathic effect and viability of 
uninfected and infected cells using MTT. Based 
on nonlinear regression analysis, IC50 of P. 
atlantica crude on ADV was 15.72 (CI 
95%:13.02-18.99) μg/mL, with SI value of 8.09 
(figure 1, table 1). Among fractions, the n-butanol 
fraction demonstrated the highest anti-adenoviral 
activity, with IC50 of 16.38 (CI 95%: 12.73-21.07) 
µg/mL and SI of 26.5 (table 1). 
 
 
Table 1. Cell cytotoxicity, anti-adenoviral activity, and selectivity index of the crude extract and various fractions of Pistacia 
atlantica 
Extract/fractions (µg/mL) 
CC50 (CI95%) 
(µg/mL) 
IC50 (CI95%) 
(µg/mL) 
SI 
Crude extract  127.2(110.2-146.8) 15.7(13.02-18.99) 8.09 
n-Hexane fraction  302.2(258-353) >302.2 <1 
Chloroform fraction  64.5(62.03-67.2) 8.39(7.55-9.31) 7.68 
Ethyl acetate fraction  32.38(28.7-36.5) 5.85(5.2-6.58) 5.5 
n-Butanol fraction  434.7(424-445.7) 16.38(12.7-21.1) 26.5 
CC50: 50% cytotoxicity concentration; IC50: 50% inhibitory concentration; CI 95 %: confidence interval 95 ℅; SI: selectivity index
 
Figure 2. Cytotoxicity and anti-adenoviral activity of crude extract and various fractions of Pistacia atlantica. Confluent HEp-2 
cells without virus infection or infected with virus were exposed to different concentrations of the extract/ fractions for 96 h. Cell 
viability was measured by the MTT test. Values are expressed as mean (± standard error of measurement) of three experiments. 
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Our results showed that with increasing the 
concentration of extract/fractions, CPE inhibition 
became more pronounced (figure 1, p< 0.05).  
In the present study, ethyl acetate fraction showed 
the lowest IC50 for inhibition of DPPH free 
radicals (1.54±0.12) followed by chloroform 
fraction, butanol fraction, total extract and hexane. 
These results are comparable to the concentration 
of BHT that inhibited 50% of DPPH radicals (IC50) 
in the present study (33.5±3.67 μg/mL), indicating 
high antioxidant effects of ethyl acetate extract. 
Other studies have also confirmed the antioxidant 
effects of pistachio extract. The antioxidant effects 
and the amounts of phenolic compounds of P. 
atlantica leaf extract have been reported in various 
studies [19,20]. 
The antiviral effects of ethanol extract and 
different fractions of P. atlantica leaves on 
adenovirus were investigated in vitro, and total 
extract and all fractions, except for hexane, 
showed antiviral activity. The CC50 and IC50 
values (on adenovirus) of the crude extract were 
127.2 μg/mL (CI95%:110.2-146.8) and 15.7 
μg/mL (CI95%:13.02-18.99), respectively. The 
selectivity index (SI) of the extract on adenovirus 
was 8.09. The recommended IC50 value, 
characteristic of herbal extract against infectious 
diseases, is less than 100 μg/mL [21]. The crude 
extract revealed an IC50 value of 15.7μg/mL that 
is far below the recommended cut-off. Among 
fractions, the n-butanol fraction showed the 
highest anti-adenoviral activity, with an IC50 of 
16.38 (CI 95%: 12.73-21.07) µg/mL and SI of 
26.5. The SI value is a ratio that measures the 
window between cytotoxicity and antiviral 
activity by dividing the given antiviral activity 
value by the cytotoxicity value [22]. The higher 
the SI ratio, the theoretically more effective and 
safer a drug would be during in vivo treatment for 
a given viral infection. The ideal drug would be 
cytotoxic only at very high concentrations and 
shows antiviral activity at very low concentrations, 
thus yielding a high SI value and being able to 
eliminate the target virus at concentrations far 
below its cytotoxic concentration. The SI of a 
compound is a widely accepted measure of its in 
vitro efficacy for the inhibition of virus replication 
[22].  
Although no study has yet evaluated the antiviral 
effects of P. atlantica, the antiviral effects of other 
Pistacia species have been studied. Özçelik et al. 
investigated the antibacterial, antifungal and 
antiviral effects of the extracts from different parts 
of P. vera and found that these extracts had low 
antibacterial and substantial antifungal effects. 
These extracts also showed high antiviral effects 
against herpes simplex virus and parainfluenza 
virus, with seed and kernel extracts showing 
comparably more potent effects than other plant 
organs [10]. They suggested that these fatty acids 
may be associated with the antiviral, antibacterial 
and antifungal activities observed due to the 
presence of palmitic acid and linoleic acid in the 
extracts of different parts of P. vera. They also 
found that palmitic acid exhibited potent antiviral 
effects against HIV-1 and HIV-2 [10]. Besides, in 
a study on the antiviral effects of 75 plant species 
against herpes virus, Sindbis virus and Poliovirus, 
P. lentiscus extract showed the highest antiviral 
activity against herpes virus because of phenolic 
compounds in the plant [22]. The study of Rashed 
et al. also showed the antiviral effects of P. 
chinensis against herpes virus [12]. The antiviral 
activity of the pistachio extract and its various 
fractions, as well as the antimicrobial and 
antifungal activity of the pistachio in previous 
studies, have been shown to be related to the 
presence of phenolic and flavonoid compounds. 
The main phenolic compounds of leaf extracts of 
Pistacia genus include ferulic acid, vanillic acid, 
ursolic acid, caffeic acid [21], gallic acid, 
chlorogenic acid, ellagic acid, synaptic acid, 
juglone and catechin [23,24]. Various studies have 
demonstrated the antiviral effects of the above 
compounds. The inhibitory effects of caffeic acid 
and chlorogenic acid against ADV and the 
substantial antiviral effects of ursolic acid against 
adenovirus, herpes virus, coxsackievirus, 
enterovirus and hepatitis virus have been reported 
[24]. In the study of Wang et al., the antiviral 
effects of chlorogenic acid, caffeic acid, and 
quinic acid were demonstrated both in vitro and in 
vivo [25].  
In the present study, the greatest inhibitory effect 
against adenovirus was obtained for n-butanol 
fraction. which showed the least toxic effect on 
HEp-2 cells; its concentration for inhibition of 50% 
of HEp-2 cells (CC50) was 434.7 μg/mL and thus 
had the lowest cytotoxic effect. The IC50 of this 
fraction against adenovirus was 16.37 µg/mL with 
the selectivity index of 26.5, indicating that it 
showed the highest antiviral effect. 
According to the results of this study, erhanol 
extract and n-butanol fraction of P. atlantica 
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leaves showed inhibitory effects on adenovirus, 
and therefore could serve as new promising anti-
adenovirus agents; however, further studies on the 
inhibitory effects of purified compounds of this 
plant are needed to confirm this argument. 
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